Static Chart Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 18:49:15 03/08/2026 +03			5-day change	1st Jan Change
2.970 ^USD	+2.06%		+4.96%	+7.64%

07-28	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
07-17	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

Duration

Period